Top Markets
Coin of the day
Abingdon Health Plc Abingdon Health Plc

Abingdon Health Plc

ABDX
Pozycja w akcjach #39749
Established in 2008 and based in York, United Kingdom, Abingdon Health Plc is a... Established in 2008 and based in York, United Kingdom, Abingdon Health Plc is a global entity dedicated to the creation, production, and worldwide distribution of diagnostic instruments. Their product line features the AbC-19 Rapid Test, a fast-acting diagnostic for COVID-19 IgG antibodies, alongside various nucleic acid lateral flow immunoassays. They also offer Seralite, a swift lateral flow test for accurately measuring kappa and lambda immunoglobulin free light chains in blood serum. Additionally, their AppDx technology converts any smartphone into an autonomous and adaptable lateral-flow reader. Beyond these offerings, the company provides expert services in lateral flow development and manufacturing, as well as advisory support to firms in the health tech industry. Abingdon Health Plc also engages in a collaborative and co-marketing partnership with Abcam plc.
Cena akcji
$0.14287366
Ostatnia synchronizacja: 2026-08-13
Kapitalizacja rynkowa
$361.12K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
68.97%
Kraj
GB
Handel Abingdon Health Plc (ABDX)

Kategoria

Zyski dla Abingdon Health Plc (ABDX)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Abingdon Health Plc, obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Abingdon Health Plc od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.42B -
US